Sector portfolio · VC firm

SL

SV Life Sciences' Biotech portfolio

SV Life Sciences has backed 23 Biotech startups in rounds we track, $1.4B between them, shown by the stage each has reached. The best-funded is Acufocus.

23startups backed
4stages
$1.4Braised between them
Series Bbiggest stage

SV Life Sciences's profile

Segment by segment

Series B

9 startups · $484M raised

  1. Bicycle TherapeuticsBicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.United Kingdom$110M
  2. Lux BiosciencesLux Biosciences is a biotechnology company developing medicines for the treatment of ophthalmic diseases.United States$90M
  3. PPanOpticaUnited States$86M
  4. EESBATechESBATech develops fully human antibody fragments for therapeutic applications, applying the single-chain antibody framework.Switzerland$63M
  5. JBJuvaris BioTherapeuticsJuvaris BioTherapeutics develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious diseases.United States$55M
  6. AlloCureAlloCure is a clinical-stage biotechnology company based in Burlington, Massachusetts, specializing in cell therapies for kidney dUnited States$47M
  7. OOncoEthixOncoethix is a clinical-stage biotechnology company developing cancer drugs.Switzerland$19M
  8. KTKarus TherapeuticsKarus Therapeutics is a pharmaceutical research company that develops drugs to treat cancer and heart diseases.United Kingdom$7.6M

Stage not reported

6 startups · $490M raised

  1. AcuFocusAcufocus is a medical device company that develops and markets KAMRA inlay for the treatment of near vision loss.United States$170M
  2. EBR SystemsEBR Systems is a provider of wireless cardiac pacing system for millions of patients suffering from cardiac rhythm diseases.United States$161M
  3. NNeurogesXNeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.United States$92M
  4. Autifony TherapeuticsAutifony Therapeutics is a clinical-stage biotechnology company founded in 2011 as a spinout from GSK.United Kingdom$32M
  5. CSCHF SolutionsCHF Solutions designs and manufactures a device to remove excess fluid from patients suffering from fluid overload.United States$23M
  6. NTNKT TherapeuticsNKT Therapeutics is a privately held biotechnology company focused on developing therapeutics to treat cancer and other serious diseases.United States$12M

Series C and later

5 startups · $358M raised

  1. PulmocidePulmocide is a private biopharmaceutical company based in London, United Kingdom, founded in 2007.United Kingdom$110M
  2. CSA MedicalCSA Medical is a provider of innovative spray cryotherapy medical device solutions.United States$105M
  3. ArsanisArsanis is a biopharmaceutical company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.Austria$76M
  4. AdimabAdimab is a leader in the discovery and engineering of fully human monoclonal and multispecific antibodies.United States$40M
  5. OOxagenOxagen develops small molecule drugs to treat inflammatory and respiratory diseases.United Kingdom$27M

Series A

3 startups · $90M raised

  1. DTDelenex TherapeuticsDelenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.Switzerland$41M
  2. CPConvergence PharmaceuticalsConvergence Pharmaceuticals is a biotechnology company focused on the development of novel analgesics for the treatment of chronic pain.United Kingdom$35M
  3. Aligned TeleHealthAligned Telehealth is a provider of a SaaS-based platform used to offer telemedicine and healthcare management services.United States$13M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names SV Life Sciences as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like SV Life Sciences?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.